IMMU Financial Facts
Operating loss: -8.54MNet (loss): 8.24M
See Full Income Statement
Commitments and Contingencies: 0
Noncontrolling interest in subsidiary: -357.3K
See Full Balance Sheet
Earnings History for Immunomedics (IMMU)
|
Expand Research on IMMU
| Next EPS Date | 11/9/12 | EPS Growth Rate | 0.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +164.7% | Revenue Growth Rate | +12.0% |
| Average % Move 1-Wk after EPS | +4.0% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/8/13 | Q313 | $0.11 | -$0.10 | +$0.21 | $1.7M | $970K | N/A / N/A | N/A | +78.6% | Details | |
| 2/7/13 | Q213 | -$0.07 | -$0.09 | +$0.02 | $812.15K | $1.07M | N/A / N/A | N/A | +53.3% | Details | |
11/9/12  |
 |
Q113 | N/A | -$0.10 | N/A | N/A | $1.12M | N/A / N/A | N/A | N/A | N/A |
| 8/23/12 |
Q412 | -$0.10 | -$0.09 | -$0.01 | $1M | $1.66M | N/A / N/A | N/A | +28.4% | Details | |
| 2/8/12 | Q212 | $0.27 | -$0.08 | +$0.35 | $29.7M | $11.47M | N/A / N/A | N/A | +15.7% | Details | |
| 11/4/11 | Q112 | -$0.07 | -$0.09 | +$0.02 | $1.1M | $1.18M | N/A / N/A | N/A | +26.9% | Details | |
| 5/8/12 | Q112 | -$0.10 | -$0.09 | -$0.01 | $1M | $1.2M | N/A / N/A | N/A | +22.4% | Details | |
| 8/24/11 | Q411 | $0.03 | -$0.06 | +$0.09 | $11.1M | $3.43M | N/A / N/A | N/A | +24.8% | Details |
